Medicare Enrolled
Dr. Abid Hussain, MD
Internal Medicine · Hemet, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hussain from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hussain?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hussain
Dr. Abid Hussain is an internal medicine specialist in Hemet, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Hussain performed 2,151 Medicare services across 1,227 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hussain received a total of $10,703 from 69 pharmaceutical and/or device companies across 628 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hussain is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 15% volume in CA
$10,703 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,151
Medicare services
Top 15% in CA for internal medicine
1,227
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~113 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
510 | $92 | $184 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
424 | $64 | $152 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
196 | $64 | $121 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
173 | $84 | $148 |
| Annual depression screening | 152 | $19 | $40 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
121 | $133 | $235 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
91 | $65 | $154 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
79 | $102 | $285 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
61 | $143 | $350 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 59 | $20 | $45 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
58 | $32 | $50 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
55 | $225 | $485 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
54 | $10 | $25 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
47 | $40 | $108 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
17 | $19 | $40 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
17 | $93 | $250 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
13 | $111 | $284 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
12 | $32 | $50 |
| Pap smear screening test A screening test to collect and prepare a cervical or vaginal sample for laboratory analysis. |
12 | $45 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,703
Total received (2018-2024)
Avg $1,529/year across 7 years
Top 9% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
628
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,505 (98.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$198 (1.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,345
2023
$1,308
2022
$1,561
2021
$1,995
2020
$1,325
2019
$1,361
2018
$1,807
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Koya Medical, Inc.
$281
Novo Nordisk Inc
$171
AstraZeneca Pharmaceuticals LP
$145
Phathom Pharmaceuticals, Inc.
$87
Lilly USA, LLC
$81
Abbott Laboratories
$79
SHIELD THERAPEUTICS INC
$59
Boehringer Ingelheim Pharmaceuticals, Inc.
$57
Boston Scientific Corporation
$53
Lundbeck LLC
$46
GlaxoSmithKline, LLC.
$42
PFIZER INC.
$41
Dexcom, Inc.
$34
Novartis Pharmaceuticals Corporation
$34
Otsuka America Pharmaceutical, Inc.
$26
Edwards Lifesciences Corporation
$24
Shionogi Inc
$24
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$16
Janssen Pharmaceuticals, Inc
$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Sumitomo Pharma America, Inc.
$14
Top 3 companies account for 44.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,213
AstraZeneca Pharmaceuticals LP
$1,037
Janssen Pharmaceuticals, Inc
$844
Boehringer Ingelheim Pharmaceuticals, Inc.
$723
PFIZER INC.
$603
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$456
ABBVIE INC.
$454
SANOFI-AVENTIS U.S. LLC
$427
AbbVie Inc.
$339
Merck Sharp & Dohme Corporation
$331
Lilly USA, LLC
$283
Koya Medical, Inc.
$281
GlaxoSmithKline, LLC.
$252
Amgen Inc.
$252
Astellas Pharma US Inc
$198
Novartis Pharmaceuticals Corporation
$197
Abbott Laboratories
$181
Allergan, Inc.
$181
Corcept Therapeutics
$175
Eisai Inc.
$141
Vanda Pharmaceuticals Inc.
$127
Biohaven Pharmaceuticals, Inc.
$126
Xeris Pharmaceuticals, Inc.
$115
Dexcom, Inc.
$103
Phathom Pharmaceuticals, Inc.
$87
Shionogi Inc
$84
Alnylam Pharmaceuticals Inc.
$81
Lundbeck LLC
$77
Amarin Pharma Inc.
$69
Sunovion Pharmaceuticals Inc.
$63
SHIELD THERAPEUTICS INC
$59
Lantheus Medical Imaging, Inc.
$58
Biohaven Pharmaceutical Holding Company Ltd.
$55
Boston Scientific Corporation
$53
EISAI INC.
$47
AbbVie, Inc.
$46
Almatica Pharma LLC
$44
IDORSIA PHARMACEUTICALS US INC
$44
Otsuka America Pharmaceutical, Inc.
$43
Concordia Pharmaceuticals Inc.
$42
E.R. Squibb & Sons, L.L.C.
$40
Merck Sharp & Dohme LLC
$40
Mylan Specialty L.P.
$38
Bayer HealthCare Pharmaceuticals Inc.
$35
Ultragenyx Pharmaceutical Inc.
$34
UCB, Inc.
$33
MannKind Corporation
$31
Allergan Inc.
$30
SK Life Science, Inc.
$26
Edwards Lifesciences Corporation
$24
Circassia Pharmaceuticals Inc
$24
SI-BONE, Inc.
$24
Radius Health, Inc.
$24
DEXCOM, INC.
$23
Valeritas, Inc.
$23
Biogen, Inc.
$23
Nabriva Therapeutics, plc
$23
Sanofi Pasteur Inc.
$23
ViiV Healthcare Company
$22
Zealand Pharma US, Inc.
$21
Avanir Pharmaceuticals, Inc.
$21
Gilead Sciences, Inc.
$19
Otsuka Pharmaceutical Development & Commercialization, Inc.
$18
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$16
Seqirus USA Inc
$15
Medicure Pharma Inc.
$15
Regeneron Healthcare Solutions, Inc.
$15
Purdue Pharma L.P.
$15
Sumitomo Pharma America, Inc.
$14
Top 3 companies account for 28.9% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ACCRUFER · AFREZZA · AIRSUPRA · ANORO · APRETUDE · AREXVY · AVYCAZ · Aimovig · BELSOMRA · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · BYDUREON · BYSTOLIC · CAPLYTA · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CREON · Creon · Crysvita · DALVANCE · DEXCOM CGM · DEXCOM G6 TRANSMITTER · DIFICID · DONNATAL · DUPIXENT · Dayspring · Dayvigo · Definity · Dexcom G6 Transmitter · Donnatal · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · FARXIGA · FLUCELVAX QUADRIVALENT · FLUZONE HIGH-DOSE · FREESTYLE LIBRE · FREESTYLE LIBRE 3 · Fetroja · GEMTESA · GIVLAARI · GRALISE · GVOKE HYPOPEN · GVOKE PFS · HETLIOZ · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LINZESS · LONHALA MAGNAIR · LYRICA · MOUNJARO · MYRBETRIQ · NUEDEXTA · NURTEC ODT · OXBRYTA · Otezla · Ozempic · PRADAXA · PRALUENT · PREMARIN · PREVNAR - 13 · Prolia · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYMPROIC · SYNJARDY · Saxenda · TEFLARO · TOUJEO · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · Tresiba · Tymlos · UBRELVY · UTIBRON · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · VOQUEZNA · VRAYLAR · Vascepa · Victoza · Vimpat · WATCHMAN FLX · Wegovy · XARELTO · XIFAXAN · Xenleta · Yupelri · ZYPITAMAG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for internal medicine in CA.
Geographic Context
Internal medicine physicians within 10 mi
337
Per 100K population
13.8
County median income
$89,672
Nearest hospital
HEMET GLOBAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hussain is a clinical cardiology specialist, with above-average Medicare volume (top 15% in CA), with low-engagement industry engagement in the top 9% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hussain experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Hussain performed 510 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hussain receive payments from pharmaceutical companies?
Yes. Dr. Hussain received a total of $10,703 from 69 companies across 628 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hussain's costs compare to other internal medicine physicians in Hemet?
Dr. Hussain's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hussain) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Hemet
Browse internal medicine physicians in Hemet ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology